| Literature DB >> 27920637 |
Ilenia Maini1, Ivan Ivanovski2, Alessandro Iodice3, Simonetta Rosato4, Marzia Pollazzon4, Manuela Mussini4, Elga F Belligni5, Charles Coutton6, Maria Marinelli7, Veronica Barbieri7, Manuela Napoli8, Rosario Pascarella8, Chiara Sartori9, Francesca Madia10, Carlo Fusco7, Fabrizia Franchi7, Maria E Street9, Livia Garavelli4.
Abstract
To date, 5 cases of 17p13.1 microduplications have been described in the literature. Intellectual disability was reported as the core feature, together with minor facial dysmorphisms and obesity, but a characteristic phenotype for 17p13.1 microduplication has not been delineated. Here, we describe a patient with a 1.56-Mb de novo duplication in 17p13.1, affected by mild intellectual disability, facial dysmorphisms, obesity, and diabetes. By comparing the different phenotypes of currently described cases, we delineated the main clinical features of 17p13.1 microduplication syndrome. All patients described to date had variable facial dysmorphisms; therefore, it was difficult to define a common facial gestalt. Furthermore, we stress endocrinological abnormalities as important features and the need to monitor these over time.Entities:
Keywords: Diabetes; Endocrine disorders; Intellectual disability; Microduplication syndrome 17p13.1; Obesity
Year: 2016 PMID: 27920637 PMCID: PMC5131335 DOI: 10.1159/000450718
Source DB: PubMed Journal: Mol Syndromol ISSN: 1661-8769